117 related articles for article (PubMed ID: 34107771)
1. Short Communication: Persistence of HIV After Allogeneic Bone Marrow Transplant in a Dually Infected Individual.
Capoferri AA; Redd AD; Gocke CD; Clark LR; Ambinder RF; Durand CM
AIDS Res Hum Retroviruses; 2022 Jan; 38(1):33-36. PubMed ID: 34107771
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: Rebound HIV Viremia With Meningoencephalitis After Antiretroviral Therapy Interruption After Allogeneic Bone Marrow Transplant.
Capoferri AA; Redd AD; Gocke CD; Clark LR; Quinn TC; Ambinder RF; Durand CM
J Acquir Immune Defic Syndr; 2022 Mar; 89(3):297-302. PubMed ID: 34753870
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study.
Durand CM; Capoferri AA; Redd AD; Zahurak M; Rosenbloom DIS; Cash A; Avery RK; Bolaños-Meade J; Bollard CM; Bullen CK; Flexner C; Fuchs EJ; Gallant J; Gladstone DE; Gocke CD; Jones RJ; Kasamon YL; Lai J; Levis M; Luznik L; Marr KA; McHugh HL; Mehta Steinke S; Pham P; Pohlmeyer C; Pratz K; Shoham S; Wagner-Johnston N; Xu D; Siliciano JD; Quinn TC; Siliciano RF; Ambinder RF
Lancet HIV; 2020 Sep; 7(9):e602-e610. PubMed ID: 32649866
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant.
Salgado M; Kwon M; Gálvez C; Badiola J; Nijhuis M; Bandera A; Balsalobre P; Miralles P; Buño I; Martinez-Laperche C; Vilaplana C; Jurado M; Clotet B; Wensing A; Martinez-Picado J; Diez-Martin JL;
Ann Intern Med; 2018 Nov; 169(10):674-683. PubMed ID: 30326031
[TBL] [Abstract][Full Text] [Related]
5. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
[TBL] [Abstract][Full Text] [Related]
6. Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4
Jones BR; Miller RL; Kinloch NN; Tsai O; Rigsby H; Sudderuddin H; Shahid A; Ganase B; Brumme CJ; Harris M; Poon AFY; Brockman MA; Fromentin R; Chomont N; Joy JB; Brumme ZL
J Virol; 2020 Feb; 94(5):. PubMed ID: 31776273
[TBL] [Abstract][Full Text] [Related]
7. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
[TBL] [Abstract][Full Text] [Related]
8. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
9. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
Cummins NW; Rizza S; Litzow MR; Hua S; Lee GQ; Einkauf K; Chun TW; Rhame F; Baker JV; Busch MP; Chomont N; Dean PG; Fromentin R; Haase AT; Hampton D; Keating SM; Lada SM; Lee TH; Natesampillai S; Richman DD; Schacker TW; Wietgrefe S; Yu XG; Yao JD; Zeuli J; Lichterfeld M; Badley AD
PLoS Med; 2017 Nov; 14(11):e1002461. PubMed ID: 29182633
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption.
Giron LB; Papasavvas E; Yin X; Goldman AR; Tang HY; Palmer CS; Landay AL; Li JZ; Koethe JR; Mounzer K; Kostman JR; Liu Q; Montaner LJ; Abdel-Mohsen M
mBio; 2021 Feb; 12(1):. PubMed ID: 33622719
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
[TBL] [Abstract][Full Text] [Related]
12. HIV Persistence in Adipose Tissue Reservoirs.
Couturier J; Lewis DE
Curr HIV/AIDS Rep; 2018 Feb; 15(1):60-71. PubMed ID: 29423731
[TBL] [Abstract][Full Text] [Related]
13. Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients.
Nicolas A; Migraine J; Dutrieux J; Salmona M; Tauzin A; Hachiya A; Estaquier J; Molina JM; Clavel F; Hance AJ; Mammano F
Microbiol Spectr; 2022 Aug; 10(4):e0078422. PubMed ID: 35770985
[TBL] [Abstract][Full Text] [Related]
14. Infectious Virus Persists in CD4
Abreu CM; Veenhuis RT; Avalos CR; Graham S; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Clements JE; Gama L
J Virol; 2019 Aug; 93(15):. PubMed ID: 31118264
[TBL] [Abstract][Full Text] [Related]
15. The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation.
Abrahams MR; Joseph SB; Garrett N; Tyers L; Moeser M; Archin N; Council OD; Matten D; Zhou S; Doolabh D; Anthony C; Goonetilleke N; Karim SA; Margolis DM; Pond SK; Williamson C; Swanstrom R
Sci Transl Med; 2019 Oct; 11(513):. PubMed ID: 31597754
[TBL] [Abstract][Full Text] [Related]
16. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.
Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS
Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738
[TBL] [Abstract][Full Text] [Related]
17. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
Aamer HA; McClure J; Ko D; Maenza J; Collier AC; Coombs RW; Mullins JI; Frenkel LM
PLoS Pathog; 2020 Aug; 16(8):e1008791. PubMed ID: 32841299
[TBL] [Abstract][Full Text] [Related]
18. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.
Omondi FH; Chandrarathna S; Mujib S; Brumme CJ; Jin SW; Sudderuddin H; Miller RL; Rahimi A; Laeyendecker O; Bonner P; Yue FY; Benko E; Kovacs CM; Brockman MA; Ostrowski M; Brumme ZL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602611
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.
Milpied N; Fielding AK; Pearce RM; Ernst P; Goldstone AH
J Clin Oncol; 1996 Apr; 14(4):1291-6. PubMed ID: 8648386
[TBL] [Abstract][Full Text] [Related]
20. Measuring the Inducible, Replication-Competent HIV Reservoir Using an Ultra-Sensitive p24 Readout, the Digital ELISA Viral Outgrowth Assay.
Stuelke EL; James KS; Kirchherr JL; Allard B; Baker C; Kuruc JD; Gay CL; Margolis DM; Archin NM
Front Immunol; 2020; 11():1971. PubMed ID: 32849659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
